Trial Information

Summary: A Double-Blind, Placebo-Controled Trial of Olanzapine Add-On Therapy in the Treatment of Acute Syndromal and Subsyndromal Exacerbations in Bipolar Disorder

We are examining the use of olanzapine (Zyprexa) in the treatment of patients experiencing increases in symptoms of bipolar disorder. In this study, patients will be instructied to add olanzapine or a placebo to their current stable medication regiment for a period of one week, after which all patients will receive Zyprexa for one week while being monitored by a psychiatrist using clinical and laboratory measures.

Those eligible to participate will not be charged for taking part in the investigation and will receive treatment at no cost.

For additional information, please call (650) 498-4968 or visit our website at www.bipolar.org.

If you would like to learn more about participating in this study, please send an e-mail message using the form below.